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RECENT success with clinical small bowel transplan-
tation I has enabled further study of the complex 
immunology inherent to this allograft.2 Previous histo-
pathologic studies have been informative3; however. it is 
important to describe the functional role of graft lympho-
cyte populations. This is possible only by propagation of 
lamina propria associated lymphocytes for in vitro func-
tional assay. 
MATERIALS AND METHODS 
Lymphocytes were propagated from serial proxima! and distal 
mucosal biopsies by culturing divided biopsies for 2 weeks in 
RPMII640 plus 5% human AB serum. and 30 U/mL recombinant 
interleukin-2. Propagated lymphocytes were tested for primed 
proliferative activity (PL TI when challenged with imdiated donor 
splenocytes or host cells in a 3-day assay. Proliferative activity 
was measured as uptake of tritiated thymidine. Lymphocytes 
were also tested for cytotoxic activity against donor splenocyte 
ta.rgets or host cells labeled with "Cr in a standard 4-hour 
cell-mediated lympholysis (CML) assay. Propagated cells were 
then stained for immunophenotype analysis using two-<:olor ftow 
cytometric analysis. 
RESULTS 
Twenty-seven of 36 biopsies yielded T lymphocytes that 
had donor-specific PLT activity. However. only 15 of the 
27 populations with donor-specific PL T activity were 
taken from biopsies that were histologically consistent 
with rejection. Twenty of 36 propagated lymphocyte pop-
ulations were tested for CML activity. Seven of the 20 
tested yielded donor-specific cytotoxicity. One hundred 
percent (seven of seven) of the donor-specific cytotoxic T 
cells (CTLs) were propagated from biopsies taken during 
clinical episodes of rejection. None of 36 manifested 
activity against host-derived cells. consistent with the 
absence of graft-vs-host disease (GVHD) in these patients. 
Finally. CD4/CD8 ratios were different in the proximal 
graft as compared with the distal portion of the graft. Both 
were different from the peripheral blood CD4/CD8 ratios. 
There was no specific increase in anyone population of T 
cells during rejection. 
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CONCLUSIONS 
T cells demonstrating donor-specific PLT activity were 
propapted regardless of the patients' clinical status. 
These cells likely represent adequately suppressed immu-
nocompetent lymphocytes infiltrating the graft lamina pro-
pria. Their potential capabilities are suppressed by local 
endogenous factors and/or therapeutic FK S06 concentra-
tions. CTLs were absent when the patients were free of 
rejection; however. when the patients rejected. donor-
specific CTLs were propagated. The presence of both 
donor-specific PLT and CML activity was significantly 
associated with rejection (P < .05). It is also imponant to 
note that no host-specific PLT activity was manifested by 
any of the propagated T cells. This correlates with the 
absence of clinical GVHD episodes in all of the patients. 
This finding also substantiates previous reports that these 
grafts became repopulated with a lymphoreticular network 
of host origin4 as these cells certainly would not manifest 
any host-specific PLT or CML activity. This study also 
suggests that the lymphoreticular network of the small 
bowel allograft maintains focaily distinct populations of T 
cells. There was no correlation with the predominance of 
anyone subpopulation and the occurrence of rejection. 
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